Cetek Corporation

company

About

Cetek Corporation is a biopharmaceutical company that engages in the discovery and development of novel cancer therapeutics.

  • 101 - 250

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$14M
Industries
Biopharma,Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 1996
Number Of Employee
101 - 250
Operating Status
Active

Cetek Corporation is a biopharmaceutical company that engages in the discovery and development of novel cancer therapeutics. Its products include CTK110, a small molecule that shows in vitro and initial in vivo anticancer activity; CTK-100144, which has potent activity in vitro biochemical and cell-based assays; and CTK-100147 small molecules with highly selective and low nano-molar potency against the chymotrypsin.

Cetek Corporation also provides contract services and discovery collaborations for various targets and therapeutic areas. The company was founded in 1996 and is headquartered in Marlborough, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$20M
Cetek Corporation has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Apr 2, 2003 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 2, 2003 Series Unknown $6M 1 Detail
Oct 12, 2001 Series Unknown $14M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cetek Corporation is funded by 1 investors. Gainesborough Investment Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Gainesborough Investment Partners Series Unknown